Accenture (NYSE: ACN) CEO Americas logs planned stock sales under 10b5-1
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Accenture plc CEO-The Americas John F. Walsh reported planned insider stock sales under a Rule 10b5-1 trading plan. On January 27, 2026, he sold several blocks of Accenture Class A ordinary shares at weighted average prices between $275.277 and $280 per share.
All transactions were direct sales of non-derivative shares. After these trades, Walsh beneficially owned 27,221 Class A ordinary shares directly. The filing notes that each price represents a weighted average from multiple trades within the stated price ranges.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,986 shares ($1,101,644)
Net Sell
5 txns
Insider
Walsh John F
Role
CEO-The Americas
Sold
3,986 shs ($1.10M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A ordinary shares | 524 | $275.277 | $144K |
| Sale | Class A ordinary shares | 2,600 | $276.152 | $718K |
| Sale | Class A ordinary shares | 429 | $277.2489 | $119K |
| Sale | Class A ordinary shares | 421 | $278.1576 | $117K |
| Sale | Class A ordinary shares | 12 | $280.00 | $3K |
Holdings After Transaction:
Class A ordinary shares — 30,683 shares (Direct)
Footnotes (1)
- Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. The transaction was executed in multiple trades at prices ranging from $274.745 to $275.645. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades at prices ranging from $275.775 to $276.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades at prices ranging from $276.785 to $277.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades at prices ranging from $277.81 to $278.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
FAQ
What insider transaction did Accenture (ACN) report for John F. Walsh?
Accenture reported that CEO-The Americas John F. Walsh sold Class A ordinary shares in multiple transactions on January 27, 2026. These were direct sales of non-derivative shares, executed as part of a pre-established Rule 10b5-1 trading plan disclosed in the filing.
Were John F. Walsh’s Accenture (ACN) stock sales pre-planned?
Yes. The filing states the disposition of Accenture plc Class A ordinary shares was made under a Rule 10b5-1 trading plan. Such plans allow insiders to schedule trades in advance, providing a structured framework for selling shares over time.
What type of securities did the Accenture (ACN) Form 4 cover?
The Form 4 covers non-derivative Accenture plc Class A ordinary shares. All reported transactions on January 27, 2026 are coded as sales and shown as directly owned, with no derivative securities listed in Table II for this particular filing.
Does the Accenture (ACN) Form 4 mention any derivative or option activity?
No derivative or option activity is reported. Table II for derivative securities is present but contains no entries. The only transactions disclosed are sales of non-derivative Class A ordinary shares directly owned by John F. Walsh on January 27, 2026.